PRESS RELEASE published on 12/02/2024 at 22:30, 1 year 3 months ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2024 Nombre total des droits de vote et d'actions composant le capital social au 30 novembre 2024 selon l'AMF Droits De Vote Capital Social Actions AMF NYSE Euronext Paris
PRESS RELEASE published on 12/02/2024 at 22:30, 1 year 3 months ago Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 Company provides update on total voting rights and shares as of November 30, 2024 in compliance with AMF regulations Shares Total Voting Rights AMF Regulations NYSE Euronext Paris November 30 2024
BRIEF published on 11/20/2024 at 15:33, 1 year 4 months ago Franchissement de Seuils par Braidwell LP chez DBV Technologies Investissement Actions Franchissement De Seuils DBV Technologies Braidwell LP
BRIEF published on 11/20/2024 at 15:33, 1 year 4 months ago Braidwell LP Crosses Thresholds at DBV Technologies Actions Investment Crossing Thresholds DBV Technologies Braidwell LP
PRESS RELEASE published on 11/20/2024 at 15:28, 1 year 4 months ago Franchissement de seuils Déclaration de franchissement de seuils de 5% du capital et des droits de vote de DBV TECHNOLOGIES par Braidwell LP1 pour le compte de fonds gérés, avec 6 668 924 actions détenues Fonds DBV Technologies Franchissement Seuils Braidwell LP1
BRIEF published on 11/06/2024 at 22:35, 1 year 4 months ago DBV Technologies Facing Financial Uncertainties in Q3 2024 Financial Results Cash Flow Net Loss Q3 2024 DBV Technologies
BRIEF published on 11/06/2024 at 22:35, 1 year 4 months ago DBV Technologies face aux incertitudes financières au troisième trimestre 2024 Résultats Financiers Perte Nette Des Flux De Trésorerie DBV Technologies 3e Trimestre 2024
PRESS RELEASE published on 11/06/2024 at 22:30, 1 year 4 months ago DBV Technologies Reports Third Quarter 2024 Financial Results DBV Technologies reports Q3 2024 financial results, with $46.4 million cash balance. Approves quarterly financial statements. Faces challenges in securing future financing Financial Results Financing Clinical Trials Cash Balance DBV Technologies
BRIEF published on 10/31/2024 at 09:05, 1 year 4 months ago Franchissement des seuils par Braidwell LP dans DBV Technologies Actions Bons De Souscription DBV Technologies Seuil De Participation Braidwell LP
BRIEF published on 10/31/2024 at 09:05, 1 year 4 months ago Braidwell LP Crosses Thresholds in DBV Technologies Warrants Actions DBV Technologies Participation Threshold Braidwell LP
Published on 03/23/2026 at 08:00, 2 hours 22 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 8 hours 22 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 09:19, 1 hour 3 minutes ago Mister Spex Chooses Salesforce to further develop its Omnichannel Strategy
Published on 03/23/2026 at 09:00, 1 hour 22 minutes ago EQS Group launches Risk Management module to support continuous data and AI risk oversight
Published on 03/23/2026 at 08:10, 2 hours 12 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 15 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 15 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 16 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 16 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
